Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Falsely Undetectable Prostate-Specific Antigen (PSA) Due to Presence of an Inhibitory Serum Factor: A Case Report and Review of Pertinent Literature.

Loudas NB, Killeen AA, Palamalai V, Weight CJ, Rao A, Cho LC.

Am J Case Rep. 2019 Aug 24;20:1248-1252. doi: 10.12659/AJCR.917137.

2.

Analysis of vitamin levels and deficiencies in bariatric surgery patients: a single-institutional analysis.

Johnson LM, Ikramuddin S, Leslie DB, Slusarek B, Killeen AA.

Surg Obes Relat Dis. 2019 Jul;15(7):1146-1152. doi: 10.1016/j.soard.2019.04.028. Epub 2019 May 2.

PMID:
31202681
3.

Serum Sodium and Pulse Pressure in SPRINT.

Nowak KL, Chonchol M, Jovanovich A, You Z, Bates J, Foy C, Glasser S, Killeen AA, Kostis J, Rodriguez CJ, Segal M, Simmons DL, Taylor A, Lovato LC, Ambrosius WT, Supiano MA; SPRINT Research Group.

Am J Hypertens. 2019 Jun 11;32(7):649-656. doi: 10.1093/ajh/hpz055.

PMID:
30977767
4.

Tumor Lysis Syndrome.

Williams SM, Killeen AA.

Arch Pathol Lab Med. 2019 Mar;143(3):386-393. doi: 10.5858/arpa.2017-0278-RS. Epub 2018 Nov 30.

PMID:
30499695
5.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
6.

Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.

Malhotra R, Craven T, Ambrosius WT, Killeen AA, Haley WE, Cheung AK, Chonchol M, Sarnak M, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Am J Kidney Dis. 2019 Jan;73(1):21-30. doi: 10.1053/j.ajkd.2018.07.015. Epub 2018 Oct 2.

PMID:
30291012
7.

Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults.

Li D, Radulescu A, Shrestha RT, Root M, Karger AB, Killeen AA, Hodges JS, Fan SL, Ferguson A, Garg U, Sokoll LJ, Burmeister LA.

JAMA. 2017 Sep 26;318(12):1150-1160. doi: 10.1001/jama.2017.13705.

8.

Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.

Beddhu S, Rocco MV, Toto R, Craven TE, Greene T, Bhatt U, Cheung AK, Cohen D, Freedman BI, Hawfield AT, Killeen AA, Kimmel PL, Lash J, Papademetriou V, Rahman M, Rastogi A, Servilla K, Townsend RR, Wall B, Whelton PK; SPRINT Research Group.

Ann Intern Med. 2017 Sep 19;167(6):375-383. doi: 10.7326/M16-2966. Epub 2017 Sep 5.

PMID:
28869987
9.

Effects of Intensive BP Control in CKD.

Cheung AK, Rahman M, Reboussin DM, Craven TE, Greene T, Kimmel PL, Cushman WC, Hawfield AT, Johnson KC, Lewis CE, Oparil S, Rocco MV, Sink KM, Whelton PK, Wright JT Jr, Basile J, Beddhu S, Bhatt U, Chang TI, Chertow GM, Chonchol M, Freedman BI, Haley W, Ix JH, Katz LA, Killeen AA, Papademetriou V, Ricardo AC, Servilla K, Wall B, Wolfgram D, Yee J; SPRINT Research Group.

J Am Soc Nephrol. 2017 Sep;28(9):2812-2823. doi: 10.1681/ASN.2017020148. Epub 2017 Jun 22.

10.

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT).

Weiner DE, Gaussoin SA, Nord J, Auchus AP, Chelune GJ, Chonchol M, Coker L, Haley WE, Killeen AA, Kimmel PL, Lerner AJ, Oparil S, Saklayen MG, Slinin YM, Wright CB, Williamson JD, Kurella Tamura M; SPRINT Study Research Group.

Am J Kidney Dis. 2017 Sep;70(3):357-367. doi: 10.1053/j.ajkd.2017.04.021. Epub 2017 Jun 9.

11.

Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.

Rocco MV, Chapman A, Chertow GM, Cohen D, Chen J, Cutler JA, Diamond MJ, Freedman BI, Hawfield A, Judd E, Killeen AA, Kirchner K, Lewis CE, Pajewski NM, Wall BM, Yee J; SPRINT Research Group.

Am J Nephrol. 2016;44(2):130-40. doi: 10.1159/000448722. Epub 2016 Aug 12.

12.

Extreme Hyperferritinemia: ‚ÄČCauses and Impact on Diagnostic Reasoning.

Sackett K, Cunderlik M, Sahni N, Killeen AA, Olson AP.

Am J Clin Pathol. 2016 May;145(5):646-50. doi: 10.1093/ajcp/aqw053.

PMID:
27247369
13.

Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.

Still CH, Craven TE, Freedman BI, Van Buren PN, Sink KM, Killeen AA, Bates JT, Bee A, Contreras G, Oparil S, Pedley CM, Wall BM, White S, Woods DM, Rodriguez CJ, Wright JT Jr; SPRINT Study Research Group.

J Am Soc Hypertens. 2015 Sep;9(9):670-9. doi: 10.1016/j.jash.2015.06.012. Epub 2015 Aug 7.

14.

Verifying performance characteristics of quantitative analytical systems: calibration verification, linearity, and analytical measurement range.

Killeen AA, Long T, Souers R, Styer P, Ventura CB, Klee GG.

Arch Pathol Lab Med. 2014 Sep;138(9):1173-81. doi: 10.5858/arpa.2013-0051-CP.

PMID:
25171699
15.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT Jr, Whelton PK; SPRINT Study Research Group.

Clin Trials. 2014 Oct;11(5):532-46. doi: 10.1177/1740774514537404. Epub 2014 Jun 5. Erratum in: Clin Trials. 2017 Apr;14(2):222.

16.

Recent trends in performance and current state of creatinine assays.

Killeen AA, Ashwood ER, Ventura CB, Styer P.

Arch Pathol Lab Med. 2013 Apr;137(4):496-502. doi: 10.5858/arpa.2012-0134-CP.

PMID:
23544939
17.

Association between celiac disease and iron deficiency in Caucasians, but not non-Caucasians.

Murray JA, McLachlan S, Adams PC, Eckfeldt JH, Garner CP, Vulpe CD, Gordeuk VR, Brantner T, Leiendecker-Foster C, Killeen AA, Acton RT, Barcellos LF, Nickerson DA, Beckman KB, McLaren GD, McLaren CE.

Clin Gastroenterol Hepatol. 2013 Jul;11(7):808-14. doi: 10.1016/j.cgh.2013.02.009. Epub 2013 Feb 13.

18.

Genome-wide association study identifies genetic loci associated with iron deficiency.

McLaren CE, Garner CP, Constantine CC, McLachlan S, Vulpe CD, Snively BM, Gordeuk VR, Nickerson DA, Cook JD, Leiendecker-Foster C, Beckman KB, Eckfeldt JH, Barcellos LF, Murray JA, Adams PC, Acton RT, Killeen AA, McLaren GD.

PLoS One. 2011 Mar 31;6(3):e17390. doi: 10.1371/journal.pone.0017390.

19.

Laboratory sanctions for proficiency testing sample referral and result communication: a review of actions from 1993-2006.

Killeen AA.

Arch Pathol Lab Med. 2009 Jun;133(6):979-82. doi: 10.1043/1543-2165-133.6.979. Review.

PMID:
19492893
20.

State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry.

Miller WG, Myers GL, Ashwood ER, Killeen AA, Wang E, Ehlers GW, Hassemer D, Lo SF, Seccombe D, Siekmann L, Thienpont LM, Toth A.

Arch Pathol Lab Med. 2008 May;132(5):838-46. doi: 10.1043/1543-2165(2008)132[838:SOTAIT]2.0.CO;2.

PMID:
18466033
21.

Protein self-organization patterns in dried serum reveal changes in B-cell disorders.

Killeen AA, Ossina N, McGlennen RC, Minnerath S, Borgos J, Alexandrov V, Sarvazyan A.

Mol Diagn Ther. 2006;10(6):371-80.

PMID:
17154654
23.

Creatinine measurement: state of the art in accuracy and interlaboratory harmonization.

Miller WG, Myers GL, Ashwood ER, Killeen AA, Wang E, Thienpont LM, Siekmann L.

Arch Pathol Lab Med. 2005 Mar;129(3):297-304.

PMID:
15737021
24.

College of American Pathologists 2003 fresh frozen serum proficiency testing studies.

Klee GG, Killeen AA.

Arch Pathol Lab Med. 2005 Mar;129(3):292-3. Review. No abstract available.

PMID:
15737018
25.

Interactive effects of the ACE DD polymorphism with the NOS III homozygous G849T (Glu298-->Asp) variant in determining endothelial function in coronary artery disease.

Schmidt MA, Chakrabarti AK, Kehrer C, Pfeninnger D, Brook RD, Kaciroti N, Duvernoy C, Killeen AA, Rajagopalan S.

Vasc Med. 2003;8(3):177-83.

PMID:
14989558
26.

Linked linear amplification for simultaneous analysis of the two most common hemochromatosis mutations.

Killeen AA, Breneman JW 3rd, Carillo AR, Ugozzoli LA, Lowery JD, Liu J, Hixson CS.

Clin Chem. 2003 Jul;49(7):1050-7. Erratum in: Clin Chem. 2003 Oct;49(10):1716.

27.

Exploiting the enzymatic recognition of an unnatural base pair to develop a universal genetic analysis system.

Moser MJ, Marshall DJ, Grenier JK, Kieffer CD, Killeen AA, Ptacin JL, Richmond CS, Roesch EB, Scherrer CW, Sherrill CB, Van Hout CV, Zanton SJ, Prudent JR.

Clin Chem. 2003 Mar;49(3):407-14.

28.

Certification in molecular pathology in the United States (Training and Education Committee, The Association for Molecular Pathology).

Killeen AA, Leung WC, Payne D, Sabath DE, Snow K, Tsongalis GJ, Van Deerlin V, Weck K; Training and Education Committee, The Association for Molecular Pathology.

J Mol Diagn. 2002 Nov;4(4):181-4. No abstract available.

29.

Molecular genetic pathology: an exam, finally.

Killeen AA.

Mol Diagn. 2001 Dec;6(4):215-6. No abstract available.

PMID:
11774185
30.

Commentary: molecular analysis of congenital adrenal hyperplasia in a newborn screening program.

Killeen AA.

Mol Diagn. 2001 Sep;6(3):189-91. No abstract available.

PMID:
11571712
31.

An overview of molecular diagnosis of steroid 21-hydroxylase deficiency.

Keegan CE, Killeen AA.

J Mol Diagn. 2001 May;3(2):49-54. Review. No abstract available.

32.

Genotyping of apolipoprotein e.

Ozturk IC, Akel N, Killeen AA.

Methods Mol Med. 2001;49:451-7. doi: 10.1385/1-59259-081-0:451.

PMID:
21370160
33.
34.

Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.

Bavikatty NR, Killeen AA, Akel N, Normolle D, Schmaier AH.

Am J Clin Pathol. 2000 Aug;114(2):272-5.

PMID:
10941343
35.

Analysis of CYP21 coding polymorphisms in three ethnic populations: further evidence of nonamplifying CYP21 alleles among whites.

Ozturk IC, Wei WL, Palaniappan L, Rubenfire M, Killeen AA.

Mol Diagn. 2000 Mar;5(1):47-52.

PMID:
10837089
36.

An overview of genetic factors influencing plasma lipid levels and coronary artery disease risk.

Ozturk IC, Killeen AA.

Arch Pathol Lab Med. 1999 Dec;123(12):1219-22. Review.

PMID:
10583926
40.
41.

Genotyping of apolipoprotein E by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Srinivasan JR, Kachman MT, Killeen AA, Akel N, Siemieniak D, Lubman DM.

Rapid Commun Mass Spectrom. 1998;12(16):1045-50.

42.

Quantification of nucleic acids.

Killeen AA.

Clin Lab Med. 1997 Mar;17(1):1-19. Review.

PMID:
9138893
43.

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry as a rapid screening method to detect mutations causing Tay-Sachs disease.

Srinivasan JR, Liu YH, Venta PJ, Siemieniak D, Killeen AA, Zhu Y, Lubman DM.

Rapid Commun Mass Spectrom. 1997;11(10):1144-50.

44.

BRCA1 mutation testing: controversies and challenges.

Petty EM, Killeen AA.

Clin Chem. 1997 Jan;43(1):6-8. No abstract available.

45.
46.

Overview of current Internet resources for molecular pathology.

Killeen AA.

J Clin Lab Anal. 1996;10(6):375-9. Review. No abstract available.

47.
48.

Carbamazepine measurement in samples from the emergency room.

Chai C, Killeen AA.

Ther Drug Monit. 1994 Aug;16(4):407-12.

PMID:
7974632
49.

Quantitative analysis in molecular diagnostics.

Crotty PL, Staggs RA, Porter PT, Killeen AA, McGlennen RC.

Hum Pathol. 1994 Jun;25(6):572-9. Review.

PMID:
8013946

Supplemental Content

Loading ...
Support Center